JP Morgan Chase’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
CAM
TGA
LCM
NCM
PBPIA
5VM
AC
JP Morgan Chase's RLYB Position: Q1 2026 in Review
JP Morgan Chase increased its Rallybio (RLYB) stake by 24,870% in Q1 2026, buying an estimated $17K and bringing the position to 2,497 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6539.
JP Morgan Chase first reported a position in RLYB in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.13M in Q4 2021. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.
- JP Morgan Chase held 2,497 shares of Rallybio worth $20.1K as of Q1 2026.
- JP Morgan Chase bought 2,487 Rallybio shares in Q1 2026, an estimated $17K.
- Rallybio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6539 holding.
- JP Morgan Chase first reported a position in Rallybio in Q3 2021 and has held it in 19 quarters since.
- JP Morgan Chase's Rallybio position peaked at $3.13M in Q4 2021.
- 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.